Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) SARCOIDOSIS Study

Purpose: Sarcoidosis is a systemic disease characterized by the formation of granulomatous lesions, especially in the lungs, liver, skin, and lymph nodes; it has a heterogeneous set of clinical manifestations and a variable course for which there is not efficient long term therapies. The purpose of this study is to analyze the distinct patterns in lung microbiome (microorganisms) characteristic of Sarcoidosis and changes in the genes that impact the inflammatory response.

For more information visit the GRADS website.

Eligibility: Adults with diagnosed or suspected diagnosis of Sarcoidosis between the ages of 18 to 85 years may be eligible.

National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health
Principal Investigator: Joe G. Garcia, MD
Co-Investigator: Kenneth Knox, MD

Contact information:

(520) 626-4110 and (520) 626-8221




Study Status: 
Currently Enrolling